Mark J Ponsford

InstitutionCardiff University
AddressCardiff
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in Spetember 2020 and November 2020
    All Publications
    Bar chart showing 14 publications over 5 distinct years, with a maximum of 6 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ponsford MJ, Jefferies R, Davies C, Farewell D, Humphreys IR, Jolles S, Fairbairn S, Lewis K, Menzies D, Benjamin A, Thaivalappil F, Williams C, Barry SM. Burden of nosocomial COVID-19 in Wales: results from a multicentre retrospective observational study of 2508 hospitalised adults. Thorax. 2021 12; 76(12):1246-1249. PMID: 34301738.
      Citations: 1     Fields:    Translation:Humans
    2. Faustini SE, Jossi SE, Perez-Toledo M, Shields AM, Allen JD, Watanabe Y, Newby ML, Cook A, Willcox CR, Salim M, Goodall M, Heaney JL, Marcial-Juarez E, Morley GL, Torlinska B, Wraith DC, Veenith TV, Harding S, Jolles S, Ponsford MJ, Plant T, Huissoon A, O'Shea MK, Willcox BE, Drayson MT, Crispin M, Cunningham AF, Richter AG. Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva. Immunology. 2021 09; 164(1):135-147. PMID: 33932228.
      Citations: 7     Fields:    Translation:Humans
    3. Ponsford MJ, Burton RJ, Smith L, Khan PY, Andrews R, Cuff S, Tan L, Eberl M, Humphreys IR, Babolhavaeji F, Artemiou A, Pandey M, Jolles SRA, Underwood J. Examining the utility of extended laboratory panel testing in the emergency department for risk stratification of patients with COVID-19: a single-centre retrospective service evaluation. J Clin Pathol. 2021 Feb 19. PMID: 33608408.
      Citations:    Fields:    
    4. Moat SJ, Zelek WM, Carne E, Ponsford MJ, Bramhall K, Jones S, El-Shanawany T, Wise MP, Thomas A, George C, Fegan C, Steven R, Webb R, Weeks I, Morgan BP, Jolles S. Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens. Ann Clin Biochem. 2021 03; 58(2):123-131. PMID: 33269949.
      Citations: 7     Fields:    Translation:Humans
    5. Gill D, Ponsford MJ. Testing for antibodies to SARS-CoV-2. BMJ. 2020 11 11; 371:m4288. PMID: 33315587.
      Citations: 3     Fields:    Translation:Humans
    6. Zelek WM, Cole J, Ponsford MJ, Harrison RA, Schroeder BE, Webb N, Jolles S, Fegan C, Morgan M, Wise MP, Morgan BP. Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19. Am J Respir Crit Care Med. 2020 11 01; 202(9):1304-1308. PMID: 32897730.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    7. Ponsford MJ, Gkatzionis A, Walker VM, Grant AJ, Wootton RE, Moore LSP, Fatumo S, Mason AM, Zuber V, Willer C, Rasheed H, Brumpton B, Hveem K, Kristian Damås J, Davies N, Åsvold BO, Solligård E, Jones S, Burgess S, Rogne T, Gill D. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation. Circulation. 2020 11 03; 142(18):1791-1793. PMID: 32966752.
      Citations: 28     Fields:    Translation:HumansCellsPHPublic Health
    8. Burgess S, Ponsford MJ, Gill D. Are we underestimating seroprevalence of SARS-CoV-2? BMJ. 2020 09 03; 370:m3364. PMID: 32883673.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    9. Ponsford MJ, Price C, Farewell D, Greene G, Moore C, Perry M, Price N, Cottrell S, Steven R, El-Shanawany T, Carne E, Cousins R, Williams P, Schaub A, Vonarburg C, Jolles S. Increased Respiratory Viral Detection and Symptom Burden Among Patients with Primary Antibody Deficiency: Results from the BIPAD Study. J Allergy Clin Immunol Pract. 2021 Feb; 9(2):735-744.e6. PMID: 32841749.
      Citations: 2     Fields:    Translation:HumansCells